Depending on when you last got vaccinated, that COVID-19 shot may no longer be a good match for the variants expected to ...

Depending on when you last got vaccinated, that COVID-19 shot may no longer be a good match for the variants expected to ...

New COVID-19 strains are emerging and with it the need for updated vaccines to protect people from the virus. So how do researchers quickly update shots to keep up with mutations?

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

Jefferies analyst Michael Yee maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $55.00. The ...

The new COVID vaccine is here, but does it bring any new side effects or reactions? Here's what the COVID booster 2024 side ...

Children aged 5 to 11 years without moderate to severe immunocompromise should receive 1 dose of 2024–2025 COVID-19 vaccine (Moderna or Pfizer-BioNTech). Individuals aged 12 years and older without ...

Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and Pfizer. Jessica is a writer on the Wellness team with a focus on health ...

The FDA recently approved the updated mRNA Pfizer and Moderna boosters, as well as the updated Novavax COVID vaccine, to better target the current circulating variants in the community.

The Public Health Agency of Canada (PHAC) says updated vaccines from Moderna and Pfizer-BioNTech ... The updated mRNA vaccines target the Omicron subvariant known as KP.2. Based on Canadian ...